Assignee
EDIGENE INC
CN·0 granted patents·6 pending applications·0 citations·filing 2018–2020
Top patents by PatentIndex Score
6 records- 0151US2020384032A1Method for increasing fetal hemoglobin expression levelEDIGENE INC·Filed 2018·Application pending·0 cites
- 0251US2020339979A1Method for improving fetal hemoglobin expressionEDIGENE INC·Filed 2018·Application pending·0 cites
- 0347US2022340969A1Method for evaluating gene editing therapy based on off-target assessmentEDIGENE INC·Filed 2020·Application pending·0 cites
- 0445US2020216805A1Gene editing t cell and use thereofEDIGENE INC·Filed 2018·Application pending·0 cites
- 0544US2022307020A1Methods and compositions for editing rnasEDIGENE INC·Filed 2020·Application pending·0 cites
- 0643US2022193142A1Method for predicting effectiveness of treatment of hemoglobinopathyEDIGENE INC·Filed 2020·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →